Summary
Inhibrx , Inc.
Founded in 2011
Description
Inhibrx is a clinical stage biotechnology company that specializes in protein engineering and the development of therapeutic candidates. They have a unique pipeline of novel therapies, anchored by their proprietary single domain antibody platform. Thei...
Strengths
- Inhibrx , Inc. has a strong market share in their industry
- Demonstrating revenue growth that is faster than the industry average
- The number of employees is growing faster than the industry average
- Since Inhibrx , Inc. was founded, the company has grown faster than the industry average
Weaknesses
- Revenue generated per employee is less than the industry average
- Variance of revenue growth is more than the industry average
Annual Revenue
Inhibrx , Inc.'s annual revenue
$7271000
Based on Kona Equity data
-
Revenue per employee
$68594
-
Variance of revenue growth
3.63
-
Annual revenue growth since founding
$559308
-
Revenue growth rate from first known quarter to current
560.6%
Employee Count
106 employees
-
Employee growth rate from first known quarter to current
700.0%
Executives
Kelly Deck
Vice President, Finance
k**@inhibrx.comCarlos Bais
Executive Vice President, Translational Sciences
c**@inhibrx.comSandipan Sinha
Director, Formulation & Drug Product Manufacturing, Technical Operations
s**@inhibrx.comCarolina Bellizzi
Scientist and Lab Head, Bioanalysis
c**@inhibrx.comJason Guidry
Director, Data Management
j**@inhibrx.comNicole Anastassopoulos
Manager, Talent & Culture
n**@inhibrx.comCarson Veldstra
Director
c**@inhibrx.comChrislyn Ancheta
Process Associate
c**@inhibrx.comMarchelle Meza
Research Associate II
m**@inhibrx.comQuinn Deveraux
Executive VP, Early Research
q**@inhibrx.comMark Lappe
CEO
m**@inhibrx.comAshraf Amanullah
Executive Vice President & Technical Chief & Operations Officer
a**@inhibrx.comDave Abbott
Director, Information Technology
d**@inhibrx.comJames Kalabus
Head of Translational and Clinical Pharmacology
j**@inhibrx.comMorgan Wilson
Potency Group Leader
m**@inhibrx.comJeffrey Jensen
Executive VP, Clinical Operations
j**@inhibrx.comDana Ebbets-Reed
QA Head
d**@inhibrx.comCary Opel
Director, Cell Culture Process Development & Manufacturing
c**@inhibrx.comKevin Bayer
Senior Director, Clinical Operations
k**@inhibrx.comMichael Diprofio
Manager, Finance
m**@inhibrx.comColleen Barefield
Director, Business Development & Alliance Management
c**@inhibrx.comKathleen Burke
Controller
k**@inhibrx.comLeah Pollema
General Counsel
l**@inhibrx.comPhone Inhibrx
Chief Executive Officer
p**@inhibrx.comG Score - 4
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G1 Revenue is greater than the industry median.
- G3 Revenue growth rate from the first known quarter to current is higher than the industry average.
- G4 Employee growth rate from the first known quarter to current is higher than the industry average.
- G6 Annual revenue growth since founding is higher than the industry average.
Location
Unlock unlimited leads
Similar Companies
IGM Biosciences Inc
igmbio.com- Founded in 1993
- Location: Mountain View, CA
- Annual Revenue: $40.6M
- Employees: 216
- IGM Biosciences is pioneering a new class of antibody medicines for the treatment of cancer, infectious diseases and autoimmune and inflammatory diseases. Building upon the...
GlycoMimetics
glycomimetics.com- Founded in 2003
- Location: Rockville, MD
- Annual Revenue: $104.0K
- Employees: 52
- GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers. GlycoMimetics is a late clinical stage biotechnology company discovering and developing glycobiology based therapies for cancers...
Allakos, Inc.
allakos.com- Founded in 2012
- Location: San Carlos, California
- Annual Revenue: $64.8M
- Employees: 192
- Allakos is developing therapeutic antibodies that selectively target eosinophils and mast cells, cells that play a significant role in many diseases
Equillium Inc
equilliumbio.com- Founded in 2017
- Location: La Jolla, CA
- Annual Revenue: $9.5M
- Employees: 45
- Resetting Balance, Restoring Health | At Equillium, we are pioneering new products to treat severe autoimmune & inflammatory diseases | $EQ
HealthTell Inc
healthtell.com- Founded in 2010
- Location: San Ramon, CA
- Annual Revenue: $27.3M
- Employees: 104
- HealthTell is a biotechnology company that has developed an unprecedented platform for the early detection and classification of disease from just a simple drop of blood. Over ten years of scientific effort has demonstrated the power of the HealthTell ...
Key Information
- Name: Inhibrx , Inc.
- Category: Pharmaceuticals
- Industry: Biotechnology Company
- SIC: 87; 873
- NAICS: 5417; 541
See similar companies
-
By City La Jolla Small Biotechnology Company in La Jolla Mid-size Biotechnology Company in La Jolla Pharmaceuticals in La Jolla Small Pharmaceuticals in La Jolla Mid-size Pharmaceuticals in La Jolla
-
By State CA Small companies in CA Pharmaceuticals in CA Small Pharmaceuticals in CA Mid-size Pharmaceuticals in CA Small Biotechnology Company in CA Mid-size Biotechnology Company in CA
-
By Category Pharmaceuticals Small Pharmaceuticals Mid-size Pharmaceuticals
-
By Industry Biotechnology Company Small Biotechnology Company Mid-size Biotechnology Company Pharmaceuticals and Biotechnology Company
-
Firmographic data G Score of 4 Founded in 2011 SIC: 87 SIC: 873 NAICS: 5417 NAICS: 541 #Education General #Organizations General #Education #Organizations
Frequently Asked Questions
Inhibrx , Inc.'s headquarters are located at 11025 N. TORREY PINES Rd., Ste. 200 200 La Jolla, CA 92037.
Inhibrx , Inc.'s official website is inhibrx.com
Inhibrx , Inc.'s annual revenue is $7.3 M.
Inhibrx , Inc.'s SIC: 87; 873
Inhibrx , Inc.'s NAICS: 5417; 541.
Inhibrx , Inc. has 106 employees
Inhibrx , Inc. is in the industry of Pharmaceuticals.
